magnesium(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases hospital length of stay
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“Magnesium sulphate use was associated with prolonged ICU stay (β, 2.05; 95% CI, 1.40–2.70; P < 0.001) and hospital stay (β, 2.21; 95% CI, 0.87–3.56; P = 0.001) (Table 2).”
Quoted verbatim from Association of magnesium sulphate use with mortality in patients with acute respiratory distress syndrome: a retrospective propensity score-matched cohort study.. - Study
- cohort
- Dose
- intravenous magnesium sulphate during ICU stay; total dose mainly 1-10 g
- Population
- Adult ICU patients with ARDS in the MIMIC-IV database, propensity-score-matched cohort of magnesium sulphate users against non-users
Association of magnesium sulphate use with mortality in patients with acute respiratory distress syndrome: a retrospective propensity score-matched cohort study.2025PMID:41073637Permalink
Keep reading
- Everything the graph holds on magnesium(2+)
- Every compound studied against Hospital length of stay
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5K819SV2S9S42QX1EWZ2A4M